Raimondi A, Di Maio M, Peverelli G, Morano F, et al. Health-related quality of life in RAS wild-type metastatic colorectal cancer patients treated with panitumumab plus FOLFOX followed by panitumumab or panitumumab plus 5-FU/LV maintenance: the secondary endpoint of the Valentino study. Ann Oncol 2019;30 Suppl 4:iv115.
PMID: 32084984